The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Atlas Venture Fund Vii L P since 2010.
The trader's CIK number is 1346450.
At the time of the last reporting, Atlas Venture Fund Vii L P was the 10% Owner of Zyla Life Sciences. (stock ticker symbol ZCOR).
Also see all insider trading activities at Zyla Life Sciences.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | ABIO | 0 | $0 | 140,000 | $1,058,400 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | EGLT | 41,667 | $500,004 | 0 | $0 | 0 | $0 |
1. Arca Biopharma, Inc. (ABIO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-03-29 | ABIO | Sale | 140,000 | 7.56 | 1,058,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-02-11 | EGLT | Buy | 41,667 | 12.00 | 500,004 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atlas Venture Fund Vii L P (10% Owner of Zyla Life Sciences at the time of this reporting) see the Securities and Exchange Commission (SEC) website.